2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC7178 | |||||||||||||||||||||||
Submitter : | Ms. Trish Reynoso | Date & Time: | 03/06/2006 11:03:24 | |||||||||||||||||||||
Organization : | Ms. Trish Reynoso | |||||||||||||||||||||||
Category : | Drug Association | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Please reject the Wyeth petition (Docket # 2005P-0411) The benefit of BHRT is that it is designed for each individual. I am concerned that Wyeth?s petition would limit the ability of my physician and pharmacist to keep prescribing and preparing these individualized doses for me. The FDA should reject Wyeth's petition. | ||||||||||||||||||||||||